Access Vascularincis A Medical Technology Company Located In Billericamassachusettsthe Company Focuses On Developing Innovative Solutions To Address Complications Related To Vascular Accessparticularly In Intravenous Therapyby Utilizing A Unique Hydrophilic Biomaterialaccess Vascular Aims To Minimize Issues Such As Infectionthrombosisand Phlebitisenhancing Patient Safety And Medical Outcomes The Company S Flagship Products Include The Hydropiccaand Hydromidacatheterswhich Are Designed To Significantly Reduce Thrombus Accumulation Compared To Traditional Cathetersboth Products Are Fda Cleared And Have Received Accoladesincluding The 2022 Big Innovation Awardrecognizing Their Innovative Design And Potential To Improve Healthcare Outcomes Access Vascular Has Partnered With Capstone Health Alliance To Enhance Its Reach In The Healthcare Sectorthe Company Has Also Secured Substantial Fundingincluding A $20 Million Series B Financing Round Led By Tvm Capital Life Scienceto Support Its Product Development And Commercialization Efforts
